Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...
Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area ...
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...
Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.
PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...
M. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, ...
The announcement comes after a request was made by the Canadian Investment Regulatory Organization (CIRO) to explore the ...
The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when ...
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her ...
Andrew Iwach, MD, shares how Glaucoma 360 got its start and how today's meeting focuses on innovation that can benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback